Atomoxetine Hydrochloride
Atomoxetine Hydrochloride is a selective norepinephrine reuptake inhibitor (NRI) indicated for the treatment of ADHD. Unlike most classic ADHD medications, it is a non-stimulant. It works by increasing levels of norepinephrine, a natural chemical in the brain, which helps to improve attention span, focus, and decrease impulsivity.
Dosage by Body Weight
For pediatric patients (6 years and older) weighing up to 70 kg, the starting dose is approximately 0.5 mg/kg/day, titrated after a minimum of 3 days to a target daily dose of approximately 1.2 mg/kg. For pediatric patients weighing over 70 kg and adults, the starting dose is 40 mg/day, titrated to a target of 80 mg/day. It can be taken as a single daily dose in the morning or divided into two even doses (morning and late afternoon). Capsules must be swallowed whole and not opened.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age.
- Body Weight
- 16-20 kg
- Dose
- Not routinely recommended
- Frequency
- Only if specifically prescribed
- Tracking Notes
- Safety and efficacy are not established in patients under 20 kg. If prescribed, dosing should start at 0.5 mg/kg/day strictly under specialist supervision.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age. |
| 8-10 kg | Not recommended | Do not use | Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age. |
| 11-15 kg | Not recommended | Do not use | Safety and efficacy have not been established in patients weighing less than 20 kg or under 6 years of age. |
| 16-20 kg | Not routinely recommended | Only if specifically prescribed | Safety and efficacy are not established in patients under 20 kg. If prescribed, dosing should start at 0.5 mg/kg/day strictly under specialist supervision. |
Formulation
Purpose
Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric, adolescent, and adult patients.
Generic Name
Atomoxetine HydrochlorideBranded Drug Names
Atomoxetine Hydrochloride is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.